Company Analysis

Cytokinetics, Incorporated (CYTK)

Nasdaq: CYTK · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2003
Grade5.2
◀ Past 5.6● Present 4.4▶ Future 6.0
2 est.

Who runs Cytokinetics, Incorporated

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Blum Robert I
President & CEO. First filing Feb 2006, latest Nov 2, 2026, 164 filings in all.
Officers reporting now
5
of 14 people with a filing in the last fifteen months
Directors reporting now
9
32 people on the record since 2006
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Malik Fady IbrahamEVP Research & DevelopmentJun 2012Nov 3, 202621 · $4.9M
Blum Robert IPresident & CEOFeb 2006Nov 2, 202620 · $17.6M
Callos AndrewEVP, Chief Commercial OfficerMar 2021Aug 31, 202625 · $16.0M
Lee SungEVP, Chief Financial OfficerApr 2024Jul 2, 20265 · $5.7M
Hessekiel JeffreyChief Legal & Admin OfficerNov 2025Mar 17, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Parshall B LynnedirectorFeb 2013Nov 12, 20266 · $1.6M
Daly James MdirectorAug 2025Oct 20, 2026none
Harrington Robert ArthurdirectorApr 2022Oct 20, 20261 · $100,000
Henderson John TdirectorFeb 2009Oct 20, 20262 · $2.1M
Kaye Edward M. MddirectorMay 2016Oct 20, 20262 · $2.1M
Wierenga WendelldirectorOct 2025Oct 20, 20262 · $1.6M
Wysenski NancydirectorNov 2020Oct 20, 2026none
Landry Robert EdirectorFeb 2025Sep 15, 20262 · $100,000
Bhanji MunadirectorFeb 2021May 27, 2026none
Earlier names on the record28, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CYTK · research, not advice